0% found this document useful (0 votes)
279 views18 pages

Acute Care Presentation

This case involves a 94 pound, 5'7" female with stage IV squamous cell lung cancer and severe malnutrition who presented with shortness of breath and chest pain. During her hospital stay, she required intubation, TPN, tube feeds, and management of electrolyte abnormalities. After discussions, she was placed on a tracheostomy and PEG tube for long-term nutrition support and was transferred to a long-term acute care facility.

Uploaded by

api-650480818
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
279 views18 pages

Acute Care Presentation

This case involves a 94 pound, 5'7" female with stage IV squamous cell lung cancer and severe malnutrition who presented with shortness of breath and chest pain. During her hospital stay, she required intubation, TPN, tube feeds, and management of electrolyte abnormalities. After discussions, she was placed on a tracheostomy and PEG tube for long-term nutrition support and was transferred to a long-term acute care facility.

Uploaded by

api-650480818
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 18

Acute Care Case

Presentation:
Stage IV Lung Cancer
and Malnutrition
Alivia Oney
 Presented to the Emergency room (11/13) with SOB, chest pain
 Very confused, family indicated patient is alcohol dependent and
has a history of Wernicke’s encephalopathy.
 Korsakoff dementia?

Patient  Consulted for BMI <19 (14.98)

Presentation  DTI to coccyx, and multiple to back

Diagnoses during stay: STEMI, pneumonia, acute respiratory failure


with hypoxia, septic shock, possible Korsakoff dementia, stage IV
lung cancer, malnutrition
HT: 5’7” BP: 97/65

Anthropometrics
and Vitals WT: 94# RR: 22

BMI: 14.98* TEMP: 97.8


 PMH: COPD, CAD, PAD, A-fib, Wernicke’s encephalopathy,
possible liver cirrhosis
Patient
Medical Hx,  FMH:
Family Medical  Mother- DM, MI
 Father- unexpected early death
Hx, and Social
Hx  Social history: lives with brother, performs most ADLs, chronic
alcohol dependence, lifelong smoker
• Zithromax • Phenobarbital
• Rocephin • Ativan
• Zosyn • Valium
• Vancomycin
• Pulmozyme
• Versed
• Precedex • Iron sucrose
• Fentanyl • Senna and Colace
• Oxycodone
• Steroid inhaler
• Nitroglycerin • Albuterol
• Heparin
• Isoptin • NaCl 0.9% saline
• Digoxin • Thiamine injections
• Lovenox • Mg sulfate in D5
• Midodrine • Levophed
• Ticagrelor • Potassium bicarb
• Metoprolol • KCl tablets
• Cardizem
Medications
Patient Clinical Course:
 Initial Assessment
 Stable, not yet in ICU
 S/p chest tube placement and still confused, slow and incoherent
responses
 Per RN- poor intakes
Day 2 (first  Visible severe muscle wasting and fat loss

assessment,  WT hx? Patient family reported poor appetite/intakes and weight


loss for the past 2 months along with worsening cough and SOB
11/14)
Relevant labs: Initial intervention:
• Ca: 13.8 • ONS: Ensure Enlive and CIB milkshake
• Na: 134 at every meal
• K: 3.6
• Mg: 1.7
 Patient moved to ICU today
 Dietitian consulted for PPN order and management (no central
access)
 High nutrition risk, expecting withdrawals, dx of malnutrition
 Severe chronic disease related malnutrition

Day 3 (11/15) Labs:


• Ca: 12.4
• K: 2.9
• Na remained stable
• Mg: 1.6
 Emergency intubation overnight
 Mechanically ventilated, OG in place

 CVC placed, consulted for TPN


 Needs calculated with Penn St 2003b (vent pts), 1.5-1.8 g/kg CBW
Day 4 (11/16)  Trying to wean pressors
 Clinimix 4.25/10 @ 42 mL/hr without electrolytes + 20% fat
emulsion daily in 250 mL.
 Goal of 84 mL provides 1520 kcal, 85 g PRO, 2250 mL

 found Ca + D3 supplement
 Weaned off Levophed, but extubated (OG pulled)
 TPN continued with no changes
 Still hypercalcemic, recommended replacement of individual lytes

 NEW DX OF STAGE IV SQUAMOUS CELL LUNG CANCER


 Explains the persistent hypercalcemia

Day 5 (11/17)
 Labs today
 Ca: 12.2
 K: 3.3
 Phos: 1.1
 Na: WNL
 Mg- 1.7
 Epidemiology:
 NSCLC accounts for 84% of lung cancers
 Squamous cell- 25-30% all lung cancers
 Second most common cancer, 1st in cancer related deaths
 2020- 2.2 million new cases, 1.8 million deaths
 More common in men than women
SQUAMOUS  Etiology:

CELL LUNG  Smoking (#1 cause)


 Second-hand smoke
CANCER  Occupational carcinogens (chemicals)
 Radon, asbestos, arsenic, etc.
(NSCLC):  Clinical manifestations:
 Persistent and bloody cough, pneumonia/bronchitis, weight
loss, SOB, hypercalcemia
 Typical medical care:
 Early stages: surgery, chemotherapy, radiation therapy
 Late stages: palliative care
PATHOPHYSIOLOGY OF CONDITION

 Transformation of normal cells by DNA point mutations


 Inactivation of tumor suppressor genes (p53) and activation of oncogenes (EGFR)
 Causes damaged cells to go unchecked, progress through cell cycle (proliferate), and evade apoptosis
 Activation of telomerase.
 Angiogenesis:
 Tumor cells produce vascular endothelial growth factor- causes creation of new blood vessels from
existing vasculature to perfuse the area and allow cells to remain.
 Hallmark:
 Cavitary lesions in the central part of the lung
 Keratin pearls

 *PTHrP leads to hypercalcemia by stimulating calcium resorption from bone and


reabsorption in the kidneys.
• Prescribe increased energy and increased protein diet to meet
energy and protein needs.  
• 25-35 kcal/kg/d
• 1.0-2.5 g/kg/d
• Prescribe oral nutrition supplements to meet energy and protein
needs.
MNT for • Recommend enteral nutrition for patients who are malnourished
Patients with and unable to tolerate adequate oral diet.

Cancer • Recommend parenteral nutrition support for patients with


moderate to severe malnutrition who have inadequate enteral
nutrition or oral intake over a prolonged period.
• Provide education on malnutrition prevention and/or treatment and
its impact on overall outcomes.
• Provide education on dietary interventions to manage disease and
treatment-related side effects.
 Intubated again, OG placed
and tube feeds initiated
 New needs calculated, Penn
St 2003b, 1.5-1.8 g/kg CBW,
1 mL/kcal/d fluid
 Vital AF 1.2 at a goal rate of
50 ml/hr, 25 ml/hr flushes
Day 6  Provides: 1440 kcal, 90 g
PRO, 1573 ml fluid
(11/18)
 Labs today
 Still hypercalcemic
 K and phos still low,
replacing
 All other labs WNL
 Failed extubations x2
 Discussions for hospice/palliate care/terminal extubation
 Started receiving Pamidronate, brings down calcium levels
 Regimen cont’d with no change
Day 7-Day 11
(11/19-11/22)
Developed hypernatremia and
hyperosmolality
Increased water flushes
Switched to lower Na fluids
Day 12-20 Labs improved, remained stable since

(11/23-12-1) Family decided against comfort care

Long-term decisions made, trach (11/29)


and PEG placement (12/1)
New needs calculated, no change to
regimen
Patient being transferred to LTAC
CIB milkshake
Oral Nutrition Supplements
Ensure Enlive

Nutrition support (ventilated,


Interventions
TPN and EN
unable to eat, malnourished)

Provided
During Stay: Fluid/electrolyte Ca, K, Phos,
monitoring/management Mg, Na

Clinical judgement decisions


 NCM, Oncology General Guidance
 The Clinical Guide to Oncology Nutrition, 2006
 NIH National Library of Medicine- Squamous Cell Lung Cancer
 Medscape- Non-Small Cell Lung Cancer (NSCLC)
References  JAMA Oncology- Update of Incidence, Prevalence, Survival, and
Initial Treatment in Patients With Non-Small Cell Lung Cancer in
the US
 YouTube- Lung Cancer / Pathology - Squamous cell carcinoma (Dr.
G Bhanu Prakash Animated Medical Videos

You might also like